Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites
2009

Breakpoints in Cancer Gene Pairs and Chromosomal Fragile Sites

Sample size: 444 publication Evidence: high

Author Information

Author(s): Burrow Allison A, Williams Laura E, Pierce Levi CT, Wang Yuh-Hwa

Primary Institution: Wake Forest University School of Medicine

Hypothesis

Do breakpoints in gene pairs involved in cancer-specific recurrent translocations correlate with human chromosomal fragile sites?

Conclusion

Over half of the breakpoints in gene pairs involved in cancer-specific translocations are located at fragile sites, suggesting a role for these sites in cancer development.

Supporting Evidence

  • 52% of translocation breakpoints in gene pairs are located at fragile sites.
  • 65% of these breakpoints are at common fragile sites.
  • Translocation-prone genes exhibit characteristics of fragile DNA.

Takeaway

This study found that many cancer-related gene breakpoints are in fragile areas of our DNA, which might help explain how some cancers develop.

Methodology

The study analyzed 444 unique gene pairs involved in cancer-specific translocations and mapped their breakpoints to known fragile sites.

Limitations

The study focused only on translocations and deletions leading to fusion transcripts, excluding other types of rearrangements.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2164-10-59

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication